EUVIMEDDescoperă EUVIMED
Multizentrische StudieOpen access · CC BY-NC-ND 4.0

Sacral neuromodulation in endometriosis – A promising treatment option for chronic pelvic pain

Adrian Zegrea iD, Emilia Ojala, Pia Suvitie iD, Pirita Varpe, Heikki Huhtinen, Johanna Mäkelä-Kaikkonen, Tero Rautio, Päivi Härkki, Sinikka Salmenkylä, Mika Ukkonen, Maija Lavonius, Tarja Pinta

Acta Obstetricia et Gynecologica Scandinavica · 2023-12 · 102 (12) · 1634-1642

DOI: 10.1111/aogs.14690 ↗

At a glance

Multizentrische Studie in Acta Obstetricia et Gynecologica Scandinavica, published online on 2023-10-09. Written by Adrian Zegrea and 11 co-authors. Institution: Seinäjoki Central Hospital, Seinäjoki, Finland. Major MEDLINE topics: Endometriosis, Electric Stimulation Therapy, Chronic Pain. Cited 10 times so far (Crossref); 26 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Introduction

Chronic pelvic pain (CPP) affects over one fifth of women worldwide, and endometriosis is one of the most common causes. In the present study, we examined whether sacral neuromodulation (SNM) is effective in the treatment of refractory chronic pelvic pain in women with endometriosis. Material and methods This multicenter prospective pilot study was started in 2017 and includes patients with chronic pelvic pain with no other obvious pathology than endometriosis. Other treatment options have been tried or they are unsuitable. Patients underwent SNM implantation. The main outcome was postoperative pain reduction and secondary outcome was quality of life. The following questionnaires were used to assess the outcomes: Brief pain inventory (BPI), clinical global impression ‐ improvement (CGI‐I), 15D‐measure of health‐related quality of life, and Biberoglu and Behrman (B&B) score.

Results

A total of 35 patients underwent the SNM procedure and, at the time of analysis, 15 patients had returned one‐year questionnaires. The patients had a history of endometriosis for a median of 5.5 (interquartile range 2–9) years, with no correlation between the severity of symptoms and the duration of the disease ( p = 0.158). A total of 31 patients (89%) were implanted with the internal pulse generator. There were statistically significant changes in BPI pain‐related items. Worst experienced daily pain decreased among those who returned 12‐month questionnaires from median 9 to 5 ( p = 0.006), average daily pain from 6 to 3.5 ( p = 0.004), and least daily pain from 3 to 1 ( p = 0.004). Based on the CGI questionnaire ( n = 14), at 12 months nine patients (60%) experienced great improvement in their symptoms, three patients (20%) much improvement and two patients (13%) minimal improvement. None of the patients experienced worsening of their symptoms. There was a statistically significant change in overall 15D score at 1 month ( p < 0.001), 6 months ( p = 0.001) and 12 months ( p = 0.018), when the results were compared to baseline values. Median B&B score also improved significantly and decreased from a baseline value of 8 (4–12) to 4.5 (0–6), p = 0.002.

Conclusions

Based on the preliminary findings of our study, SNM might be a promising treatment of CPP in endometriosis patients.

Subjects

MeSH terms (MEDLINE)

EndometriosisElectric Stimulation TherapyChronic PainHumansFemaleProspective StudiesQuality of LifePilot ProjectsPelvic PainTreatment Outcome

Author keywords

chronic painendometriosispelvic painsacral neuromodulation

Authors and institutions

  • Seinäjoki Central Hospital, Seinäjoki, Finland.
  • Turku University Hospital and University of Turku, Turku, Finland.
  • Oulu University Hospital, Oulu Medical Research Center, Oulu, Finland.
  • Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
  • Tampere University Hospital and University of Tampere, Tampere, Finland.

ORCID profiles: Adrian Zegrea, Pia Suvitie

Cite

APA

Zegrea, A., Ojala, E., Suvitie, P., Varpe, P., Huhtinen, H., Mäkelä-Kaikkonen, J., Rautio, T., Härkki, P., Salmenkylä, S., Ukkonen, M., Lavonius, M., & Pinta, T. (2023). Sacral neuromodulation in endometriosis – A promising treatment option for chronic pelvic pain. Acta Obstetricia et Gynecologica Scandinavica, 102(12), 1634-1642. https://doi.org/10.1111/aogs.14690

Vancouver

Zegrea A, Ojala E, Suvitie P, Varpe P, Huhtinen H, Mäkelä-Kaikkonen J, et al. Sacral neuromodulation in endometriosis – A promising treatment option for chronic pelvic pain. Acta Obstetricia et Gynecologica Scandinavica. 2023;102(12):1634-1642. doi:10.1111/aogs.14690

BibTeX
@article{Zegrea2023,
  author = {Zegrea, Adrian and Ojala, Emilia and Suvitie, Pia and Varpe, Pirita and Huhtinen, Heikki and Mäkelä-Kaikkonen, Johanna and Rautio, Tero and Härkki, Päivi and Salmenkylä, Sinikka and Ukkonen, Mika and Lavonius, Maija and Pinta, Tarja},
  title = {Sacral neuromodulation in endometriosis – A promising treatment option for chronic pelvic pain},
  journal = {Acta Obstetricia et Gynecologica Scandinavica},
  year = {2023},
  volume = {102},
  number = {12},
  pages = {1634--1642},
  doi = {10.1111/aogs.14690}
}
Start for free →